This study is a prospective multicenter double-blind randomized controlled trial. It will recruit patients with SCAF (Sub-Clinical Atrial Fibrillation) detected by either a pacemaker, an ICD (implantable cardioverter defibrillator) or an insertable cardiac monitor (ICM); who also have other risk factors for stroke (previous stroke/TIA or systemic arterial embolism OR age ? 75 OR age 65-74 with ? 2 other risk factors OR age 55-64 with ? 3 other risk factors). Eligible and consenting patients will be randomized to receive aspirin or apixaban.
A Collaboration of the San Antonio Bioscience and Medical Research Community
A first-of-its-kind initiative between public and private sector to catalog and highlight Bioscience research in the city of San Antonio and the surrounding areas.
Latest Projects
The University of Texas at San Antonio
The University of Texas at San Antonio
Southwest Research Institute
Southwest Research Institute
The University of Texas at San Antonio